eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

Open access

without publication fees
Share:
Send email
Share:
Review paper

European Baseline Series, Polish Baseline Series, Polish Standard… Why compositions of patch test series undergo revisions and how does it influence clinical practice?

Radosław Śpiewak
1, 2
,
Grzegorz Ostrowski
3
,
Ewelina Szendzielorz
1
,
Jadwiga Kalicińska
1

  1. Zakład Dermatologii Doświadczalnej i Kosmetologii, Wydział Farmaceutyczny, Uniwersytet Jagielloński Collegium Medicum, Kraków, Polska
  2. Instytut Dermatologii sp. z o.o., Kraków, Polska
  3. Ambulatorium ‘dermatolog.eu’, Kraków, Polska
Alergologia Polska – Polish Journal of Allergology 2024; 11
DOI: https://doi.org/10.5114/pja.2024.142711
Online publish date: 2024/09/04
Article file
- Europejska Seria Podstawowa.pdf  [0.37 MB]
Get citation
 
PlumX metrics:
 
1. Śpiewak R. Diseases from the spectrum of dermatitis and eczema: Can “omics” sciences help with better systematics and more accurate differential diagnosis? Int J Mol Sci 2023; 24: 10468.
2. Nowicki RJ, Czarnecka-Operacz M, Grubska-Suchanek E, et al. Stanowisko Polskiego Towarzystwa Alergologicznego oraz Polskiego Towarzystwa Dermatologicznego w sprawie ograniczonej dostępności niezbędnych materiałów do testów płatkowych. Część I: Bariery technologiczne i prawne. Pol J Allergology 2024; 11:
3. de Groot AC. Patch testing. Test concentrations and vehicles for 5200 chemicals. Wapserveen: Acdegroot Publishing; 2022. 1-614. https://escd.org/members-area/view-patch-testing-5th-edition/ (electronic document, 26.07.2024).
4. Johansen JD, Aalto-Korte K, Agner T, et al. European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice. Contact Dermatitis 2015; 73: 195-221.
5. Śpiewak R. Patch testing for contact allergy and allergic contact dermatitis. Open Allergy J 2008; 1: 42-51.
6. Rudzki E, Kleniewska D. Polski zestaw alergenów kontaktowych. Dermatol Rev 1970; 57: 751-4.
7. Magnusson B, Blohm SG, Fregert S, et al. Routine patch testing. II. Proposed basic series of test substances for Scandinavian countries and general remarks on testing technique. Acta Derm Venereol 1966; 46: 153-8.
8. Paschoud JM. Tests de routine, tests composés et tests spécialisés. Dermatologica 1968; 136: 193-214.
9. ICDRG. https://www.icdrg.org/ (electronic document, 26.07.2024).
10. Wilkinson DS, Fregert S, Magnusson B, et al. Terminology of contact dermatitis. Acta Derm Venereol Stockh 1970; 50: 287-92.
11. ICDRG. Routine patch test series (1974). Recommendation by the International Contact Dermatitis Research Group. Br J Dermatol 1974; 89: 437-8.
12. EECDRG. https://www.eecdrg.org/ (electronic document, 26.07.2024).
13. Andersen KE, Burrows D, Cronin E, et al. Recommended changes to standard series. Contact Dermatitis 1988; 19: 389-90.
14. Belloni Fortina A, Cooper SM, Spiewak R, et al. Patch test results in children and adolescents across Europe Analysis of the ESSCA Network 2002-2010. Pediatr Allergy Immunol 2015; 26: 446-55.
15. Uter W, Śpiewak R, Cooper SM, et al. Contact allergy to ingredients of topical medications: results of the European Surveillance System on Contact Allergies (ESSCA), 2009-2012. Pharmacoepidemiol Drug Saf 2016; 25: 1305-12.
16. Loman L, Uter W, Armario-Hita JC, et al. European Surveillance System on Contact Allergies (ESSCA): characteristics of patients patch tested and diagnosed with irritant contact dermatitis. Contact Dermatitis 2021; 85: 186-97.
17. Bauer A, Pesonen M, Brans R, et al. Occupational contact allergy: the European perspective – analysis of patch test data from ESSCA between 2011 and 2020. Contact Dermatitis 2023; 88: 263-74.
18. Bandmann HJ, Fregert S. Epicutantestung. Einführung in die Praxis. Zweite, überarbeitete Auflage. Im Namen der International Contact Dermatitis Research Group. Springer, Berlin 1982; 12-3.
19. Lachapelle JM, Bruynzeel DP, Ducombs G, et al. European multicenter study of the TRUE Test. Contact Dermatitis 1988; 19: 91-7.
20. Wilkinson JD, Bruynzeel DP, Ducombs G, et al. European multicenter study of TRUE Test, Panel 2. Contact Dermatitis 1990; 22: 218-25.
21. Bruynzeel DP, Andersen KE, Camarasa JG, et al. The European standard series. European Environmental and Contact Dermatitis Research Group (EECDRG). Contact Dermatitis 1995; 33: 145-8.
22. Isaksson M, Brandão FM, Bruze M, et al. Recommendation to include budesonide and tixocortol pivalate in the European standard series. ESCD and EECDRG. European Society of Contact Dermatitis. Contact Dermatitis 2000; 43: 41-2.
23. Bruze M, Goossens A, Gruvberger B; ESCD; EECDRG. Recommendation to include methyldibromo glutaronitrile in the European standard patch test series. Contact Dermatitis 2005; 52: 24-8.
24. Jacob SE. Improvement of the T.R.U.E. Test: launch of panel 3. Dermatitis 2008; 19: 115-7.
25. Śpiewak R, Gregorius A, Grubska-Suchanek E, et al. KRAK: first multi-centre study of the new Polish baseline series. Contact Dermatitis 2012; 66 (Suppl 2): 55.
26. Śpiewak R. Alergia kontaktowa i alergiczny wyprysk kontaktowy. Pol J Allergol 2014; 1: 150-7.
27. Bruze M, Engfeldt M, Gonçalo M, et al. Recommendation to include methylisothiazolinone in the European baseline patch test series – on behalf of the European Society of Contact Dermatitis and the European Environmental and Contact Dermatitis Research Group. Contact Dermatitis 2013; 69: 263-70.
28. Isaksson M, Ryberg K, Goossens A, et al. Recommendation to include a textile dye mix in the European baseline series. Contact Dermatitis 2015; 73: 15-20.
29. Wilkinson M, Gonçalo M, Aerts O, et al. The European baseline series and recommended additions: 2019. Contact Dermatitis 2019; 80: 1-4.
30. Kruszewski J, Mazurek H, Czarnecka-Operacz M, et al. Testy skórne. In: Standardy w alergologii. Wydanie III. Stanowisko paneli eksperckich Polskiego Towarzystwa Alergologicznego. Kruszewski J, Kowalski ML, Kulus M (eds.). Termedia, Poznań 2019; 17-41.
31. Śpiewak R, Maciejewska A, Niwiński K. Jak utrzymać dobrą praktykę kliniczną w zakresie testów płatkowych w obecnych realiach? In: 19 Akademia Dermatologii i Alergologii Gdynia 10-12.02.2023. Nowicki R (ed.). Wydawnictwo Bernardinum, Pelplin 2023; 27-33.
32. Wilkinson SM, Gonçalo M, Aerts O, et al. The European baseline series and recommended additions: 2023. Contact Dermatitis 2023; 88: 87-92.
33. Śpiewak R, Maciejewska A, Niwiński K. Receptura brakujących haptenów diagnostycznych z Polskiej Serii Podstawowej do wykrywania alergii kontaktowej na leki. Pol J Allergol 2024; 11:
34. Bruze M, Condé-Salazar L, Goossens A, et al. Thoughts on sensitizers in a standard patch test series. The European Society of Contact Dermatitis. Contact Dermatitis 1999; 41: 241-50.
35. Uter W, Amario-Hita JC, Balato A, et al. European Surveillance System on Contact Allergies (ESSCA): Results with the European baseline series, 2013/14. J Eur Acad Dermatol Venereol 2017; 31: 1516-25.
36. Schwensen JF, Lundov MD, Bossi R, et al. Methylisothiazolinone and benzisothiazolinone are widely used in paint: a multicentre study of paints from five European countries. Contact Dermatitis 2015; 72: 127-38.
37. Thomsen AV, Schwensen JF, Bossi R, et al. Isothiazolinones are still widely used in paints purchased in five European countries: a follow-up study. Contact Dermatitis 2018; 78: 246-53.
38. Gupta R, Kullberg SA, Warshaw EM. Relevant contact allergy to benzisothiazolinone in a personal care product. Dermatitis 2020; 31: e13-4.
39. Kaur-Knudsen D, Menné T, Carlsen BC. Systemic allergic dermatitis following airborne exposure to 1,2-benzisothiazolin-3-one. Contact Dermatitis 2012; 67: 310-2.
40. King N, Latheef F, Wilkinson M. Trends in preservative allergy: benzisothiazolinone emerges from the pack. Contact Dermatitis 2021; 85: 637-42.
41. Uter W, Wilkinson SM, Aerts O, et al. European patch test results with audit allergens as candidates for inclusion in the European Baseline Series, 2019/20: joint results of the ESSCA and the EBS working groups of the ESCD, and the GEIDAC. Contact Dermatitis 2022; 86: 379-89.
42. DeKoven JG, Warshaw EM, Reeder MJ, et al. North American Contact Dermatitis Group patch test results: 2019-2020. Dermatitis 2023; 34: 90-104.
43. Sasseville D. Alkyl glucosides: 2017 “allergen of the year”. Dermatitis 2017; 28: 296.
44. Morin CB, Sasseville D. Expanding patch testing beyond the baseline series: usefulness of customized antimicrobials, vehicles, and cosmetics series. Dermatitis 2020; 31: 367-72.
45. Warshaw EM, Buonomo M, DeKoven JG, et al. Patch testing with sodium disulfite: North American Contact Dermatitis Group experience, 2017 to 2018. Contact Dermatitis 2021; 85: 285-96.
46. Uter W, Bauer A, Belloni Fortina A, et al. Patch test results with the European baseline series and additions thereof in the ESSCA network, 2015-2018. Contact Dermatitis 2021; 84: 109-20.
47. Ekstein SF, Warshaw EM. Sulfites: allergen of the year 2024. Dermatitis 2024; 35: 6-12.
48. Ostrowski G, Szendzielorz E, Śpiewak R. Occurrence of sodium metabisulfite in cosmetics and positivity rates among consecutive patch test patients in the same area. Congress of the European Society of Contact Dermatitis (ESCD). Dresden 2024.
49. Polek Ż, Szendzielorz E, Niewęgłowska M, et al. Analiza składu dostępnych na polskim rynku farb do włosów pod kątem występowania składników o znanym potencjale uczulającym. Pol J Allergol 2018; 5: 121-8.
50. García-Gavín J, Parente J, Goossens A. Allergic contact dermatitis caused by sodium metabisulfite: a challenging allergen: a case series and literature review. Contact Dermatitis 2012; 67: 260-9.
51. Czarnobilska E, Obtulowicz K, Dyga W, et al. The most important contact sensitizers in Polish children and adolescents with atopy and chronic recurrent eczema as detected with the extended European Baseline Series. Pediatr Allergy Immunol 2011; 22: 252-6.
52. Rebandel P, Rudzki E. Jednoczesne uczulenie na nikiel i pallad. Przegl Dermatol 1990; 77: 255-8.
53. Śpiewak R, Samochocki Z, Paśnicki M, et al. Detection of contact allergy to palladium: sodium tetrachloropalladate is better than palladium chloride. Allergy 2014; 69 (Suppl. 99): 44-5.
54. Śpiewak R, Samochocki Z, Grubska-Suchanek E, et al. Gallates, as well as hydroperoxides of limonene and linalool, are more frequent and relevant sensitizers than any cosmetic ingredient included in the European Baseline Series. Contact Dermatitis 2016; 75 (S1): 87.
55. Kalicińska J, Wiśniowska B, Śpiewak R. Irritant patch tests reactions to cosmetic ingredients. Pol J Allergology 2022; 9: 55-61.
56. Vogel TA, Heijnen RW, Coenraads PJ, et al. Two decades of p-phenylenediamine and toluene-2,5-diamine patch testing – focus on co-sensitizations in the European baseline series and cross-reactions with chemically related substances. Contact Dermatitis 2017; 76: 81-8.
57. Kieć-Świerczynska M, Kręcisz B, Chomiczewska D. Wyniki testów naskórkowych u fryzjerów badanych w Instytucie Medycyny Pracy w Łodzi. Med Pr 2009; 60: 459-67.
58. Andersen KE. Contact allergy to toothpaste flavors. Contact Dermatitis 1978; 4: 195-8.
59. Paulsen E, Andersen KE, Carlsen L, et al. Carvone: an overlooked contact allergen cross-reacting with sesquiterpene lactones? Contact Dermatitis 1993; 29: 138-43.
60. Enberg J, Hamnerius N, Kroona L, et al. The use of carvone in consecutive patch testing. Contact Dermatitis 2023; 88: 206-11.
61. Menné T, Andersen KE, Kaaber K, et al. Tin: an overlooked contact sensitizer? Contact Dermatitis 1987; 16: 9-10.
62. Aggarwal V, Jain A, Kabi D. Oral lichenoid reaction associated with tin component of amalgam restorations: a case report. Am J Dermatopathol 2010; 32: 46-8.
63. Pigatto PD, Bombeccari G, Spadari F, et al. Oral lichenoid reaction, dental amalgam, and tin allergy. Am J Dermatopathol 2011; 33: 414-5.
64. Enamandram M, Das S, Chaney KS. Cheilitis and urticaria associated with stannous fluoride in toothpaste. J Am Acad Dermatol 2014; 71: e75-6.
65. Toma N, Horst N, Dandelooy J, et al. Contact allergy caused by stannous fluoride in toothpaste. Contact Dermatitis 2018; 78: 304-6.
66. George H, Dendooven E, Leysen J, et al. Recurrent allergic contact stomatitis and aphtosis, without cheilitis, due to stannous (tin)-containing toothpastes. Contact Dermatitis 2023; 89: 509-11.
67. Nielsen NH, Skov L. Occupational allergic contact dermatitis in a patient with a positive patch test to tin. Contact Dermatitis 1998; 39: 99-100.
68. Quenan S, Huber C, Pasche-Koo F, et al. Airborne allergic contact dermatitis caused by tin. Contact Dermatitis 2014; 71: 184-5.
69. Gil F, Rato M, Monteiro A, et al. Occupational lichenoid allergic contact dermatitis caused by tin. Contact Dermatitis 2019; 81: 71-3.
70. Davis MD, Wang MZ, Yiannias JA, et al. Patch testing with a large series of metal allergens: findings from more than 1,000 patients in one decade at Mayo Clinic. Dermatitis 2011; 22: 256-71.
71. Haddad SF, Helm MM, Meath B, et al. Exploring the incidence, implications, and relevance of metal allergy to orthopaedic surgeons. J Am Acad Orthop Surg Glob Res Rev 2019; 3: e023.
72. Śpiewak R. Alergia kontaktowa na cynę: podsumowanie testów płatkowych z lat 2007–2024. XV Międzynarodowy Kongres PTA, Kraków 2024.
73. Bennike NH, Johansen JD. Sorbitan sesquioleate: a rare cause of contact allergy in consecutively patch tested dermatitis patients. Contact Dermatitis 2016; 74: 242-5.
74. Asarch A, Scheinman PL. Sorbitan sesquioleate: an emerging contact allergen. Dermatitis 2008; 19: 339-41.
75. Szendzielorz E, Ostrowski G, Śpiewak R. Occurrence of sorbitan sesquioleate and sorbitan monooleate in cosmetics and positivity rates among consecutive patch test patients in the same area. Congress of the European Society of Contact Dermatitis (ESCD). Dresden 2024.
76. de Groot A, Gilissen L, Geier J, et al. Adding sorbitan sesquioleate to the European baseline series: Necessary, reasonable, or unavoidable? Contact Dermatitis 2019; 81: 221-5.
77. Isaksson M, Bråred-Christensson J, Engfeldt M, et al. Patch testing with formaldehyde 2.0% in parallel with 1.0% by the Swedish Contact Dermatitis Research Group. Acta Derm Venereol 2014; 94: 408-10.
78. Śpiewak R, Samochocki Z, Paśnicki M et al. Methylisothiazolinone/methylchloroisothiazolinone and formaldehyde: petrolatum-based patch tests detect more sensitizations. Contact Dermatitis 2014; 70 (Suppl 1): 60-1.
79. Pokorska P, Śpiewak R. Analiza składu kosmetyków rekomendowanych przez Polskie Towarzystwo Dermatologiczne oraz Polskie Towarzystwo Alergologiczne pod kątem występowania substancji o znanym potencjale uczulającym. Alergol Immunol 2012; 9: 227-32.
80. Foti C, Bonamonte D, Mascolo G, et al. The role of 3-dimethylaminopropylamine and amidoamine in contact allergy to cocamidopropylbetaine. Contact Dermatitis 2003; 48: 194-8.
81. Nyman GSA, Giménez-Arnau AM, Grigaitiene J, et al. Patch testing with propolis of different geographical origins in a baseline series. Acta Derm Venereol 2021; 101: adv00591.
82. Schnuch A, Müller BP, Geier J. Differences in contents of organochlorine impurities do not influence responses to patch testing with Majantol. Contact Dermatitis 2017; 76: 11-8.
83. Menné T, White IR, Bruynzeel DP, et al. Patch test reactivity to the PPD-black-rubber-mix (industrial rubber chemicals) and individual ingredients. Contact Dermatitis 1992; 26: 354.
84. Ryberg K, Goossens A, Isaksson M, et al. Patch testing with a textile dye mix and its constituents in a baseline series. Dermatitis 2010; 21: 49-56.
85. Śpiewak R, Ostrowski G: Textile Dye Mix and Disperse Blue Mix: co-sensitizations and cross-reactivities. Congress of the European Society of Contact Dermatitis (ESCD). Dresden 2024.
86. John SM, Bonertz A, Zimmer J, et al. Severely compromised supply of patch test allergens in Europe hampers adequate diagnosis of occupational and non-occupational contact allergy. A European Society of Contact Dermatitis (ESCD), European Academy of Allergy and Clinical Immunology (EAACI), European Academy of Dermatology and Venereology (EADV) task forces ‘Contact Dermatitis’ and ‘Occupational Skin Disease’ position paper. Contact Dermatitis 2024; 91: 91-103.
87. Śpiewak R. Praktyka wykonywania testów płatkowych w świetle aktualnych wytycznych. Wiad Dermatol 2019; 2: 55-6.
88. Liippo J, Lammintausta K. Positive patch test reactions to gentamicin show sensitization to aminoglycosides from topical therapies, bone cements, and from systemic medication. Contact Dermatitis 2008; 59: 268-72.
89. Baeck M, Chemelle JA, Goossens A, et al. Corticosteroid cross-reactivity: clinical and molecular modelling tools. Allergy 2011; 66: 1367-74.
90. Dooms-Goossens A, Andersen KE, Brandäo FM, et al. Corticosteroid contact allergy: an EECDRG multicentre study. Contact Dermatitis 1996; 35: 40-4.
91. Lammintausta K, Zimerson E, Hasan T, et al. An epidemic of furniture-related dermatitis: searching for a cause. Br J Dermatol 2010; 162: 108-16.
92. Castelain M. Globalisation and allergy. Eur J Dermatol 2011; 21: 472-8.
93. Lundov MD, Opstrup MS, Johansen JD. Methylisothiazolinone contact allergy – growing epidemic. Contact Dermatitis 2013; 69: 271-5.
94. Kalicińska J, Wiśniowska B, Polak S, et al. Artificial intelligence that predicts sensitizing potential of cosmetic ingredients with accuracy comparable to animal and in vitro tests – how does the infotechnomics compare to other “omics” in the cosmetics safety assessment? Int J Mol Sci 2023; 24: 6801.
95. Enberg J, Hamnerius N, Mowitz M. Allergic contact dermatitis caused by a new insulin pump system containing isobornyl acrylate. Contact Dermatitis 2023; 88: 326-8.
96. Baek P, Adler BL. Allergic contact dermatitis to isobornyl acrylate in a home nail glue. Contact Dermatitis 2024; 91: 64-6.
97. Samaran Q, Raison-Peyron N, Dereure O, et al. Allergic contact dermatitis to isobornyl acrylate in a hospital wristband. Contact Dermatitis 2024; 91: 62-4.
98. Kieć-Świerczyńska M, Kręcisz B, Świerczyńska-Machura D, et al. An epidemic of occupational contact dermatitis from an acrylic glue. Contact Dermatitis 2005; 52: 121-5.
99. Cichoń M, Trzeciak M, Sokołowska-Wojdyło M, et al. Contact dermatitis to diabetes medical devices. Int J Mol Sci 2023; 24: 10697.
100. Cichoń M, Myśliwiec M, Trzeciak M. Role of acrylates in the development of contact dermatitis in diabetic patients – A Polish dermatology tertiary centre experience. Contact Dermatitis 2024; 90: 126-33.
Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.



Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.